Durham, NC, United States of America

Christine Hudson

USPTO Granted Patents = 2 


Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 47(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Celebrating the Innovations of Christine Hudson

Introduction: Christine Hudson, an accomplished inventor based in Durham, North Carolina, has made significant contributions to the field of pharmaceutical research. With two notable patents under her name, her work focuses on innovative compounds that have the potential to transform therapeutic approaches for various medical conditions.

Latest Patents: Christine's most recent patents include pioneering developments in isoquinoline compounds, which influence, inhibit, or reduce the action of G-protein receptor kinase. These compounds are integral to pharmaceutical compositions designed to treat disease states such as cancer, osteoporosis, and glaucoma. Additionally, her second patent revolves around a constitutively translocating cell line, detailing methods for screening compounds that modify GPCR desensitization. This body of work showcases her expertise in advancing drug discovery and development.

Career Highlights: Throughout her career, Christine has held prominent positions at various organizations, including Aerie Pharmaceuticals, Inc. and Molecular Devices Corporation. Her roles in these companies have allowed her to blend scientific innovation with practical applications in the pharmaceutical industry, ultimately benefiting patient care.

Collaborations: Collaborating with esteemed colleagues such as Robert H. Oakley and Mitchell Anthony deLong, Christine has leveraged her collaborative spirit to drive impactful research. Their collective efforts contribute to the broader scientific community, fostering innovations that address pressing health challenges.

Conclusion: Christine Hudson exemplifies the essence of innovation in the pharmaceutical field. Her research on isoquinoline compounds and GPCR functionality not only highlights her ingenuity but also underscores her commitment to improving therapeutic strategies. As an inventor and collaborator, Christine continues to pave the way for future discoveries that have the potential to benefit countless individuals facing health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…